Oravax, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of innovative vaccine solutions. The organization focuses on creating oral vaccines that target infectious diseases, leveraging advanced technologies to enhance immunogenicity and patient compliance. Oravax aims to address global health challenges by providing effective and accessible vaccination options, contributing to the broader field of preventive medicine and public health initiatives.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#231 in Cambridge, MA

#1,773 in Massachusetts

#29,882 in US

#56,092 in the World

Cambridge, MA, United States of America

Oravax, Inc.

Forward Citations = 210

30 inventors:

Thomas P Monath (3 out of 33 patents)

Polly Roy (3 out of 4 patents)

Wende Lei (2 out of 5 patents)

4. Zhenxi Zhang (2 out of 5 patents)

5. Jean-Pierre Kraehenbuhl (2 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oravax, Inc.. Retrieved from https://idiyas.com/company/oravax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]